{"gene":"CHSY3","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":2003,"finding":"CHSY3 (CSS3) encodes a type II membrane protein with both glucuronyltransferase (GlcAT-II) and N-acetylgalactosaminyltransferase (GalNAcT-II) activities responsible for elongation of chondroitin sulfate chains, producing GlcUAβ1-3GalNAc and GalNAcβ1-4GlcUA linkages at the nonreducing terminus, but cannot polymerize chondroitin chains alone.","method":"Recombinant enzyme expression in COS-7 cells, in vitro glycosyltransferase assays with chondroitin/CS polymer acceptor substrates","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro enzymatic characterization with defined substrates, replicated by subsequent studies","pmids":["12907687"],"is_preprint":false},{"year":2007,"finding":"CHSY3 (CSS3) interacts with ChSy-1 and ChPF via direct protein-protein interactions; co-expression of CSS3 with either ChSy-1 or ChPF confers chondroitin polymerization activity not present in CSS3 alone. Overexpression of CSS3 increases CS in HeLa cells; RNAi knockdown reduces CS levels.","method":"Pull-down assays (protein-protein interaction), co-expression in mammalian cells with glycosyltransferase activity assays, RNAi knockdown and overexpression with CS quantification in HeLa cells","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (pull-down, co-expression activity assay, RNAi, overexpression) in one study, independently replicated in subsequent work","pmids":["17253960"],"is_preprint":false},{"year":2008,"finding":"CHSY3 (renamed ChSy-3 from CSGlcA-T) interacts with ChSy-1, ChSy-2 (CSS3/CHSY3's alias used for a different member here — note: in this paper CSGlcA-T is the subject being renamed ChSy-3), and ChPF; these heteromeric complexes exhibit chondroitin polymerization activity with distinct chain lengths depending on the combination. The glycosyltransferase activity of CSGlcA-T is required for polymerization, as a catalytically inactive mutant that retains binding to other ChSy members cannot support polymerization.","method":"Co-expression in cells, in vitro polymerization assay with truncated linkage region tetrasaccharide acceptor, catalytically inactive mutant analysis, RNAi knockdown and overexpression with CS quantification in HeLa cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — active-site mutagenesis combined with reconstitution assay and RNAi, multiple orthogonal methods","pmids":["18316376"],"is_preprint":false},{"year":2025,"finding":"Cryo-EM structure of the CHSY3-CHPF heterodimeric complex reveals the molecular basis of chondroitin sulfate chain polymerization. CHSY3 contains an N-terminal GT31-like domain (transfers β1,3-GlcA) and a C-terminal GT7-like domain (transfers β1,4-GalNAc) separated by a cystatin-like linker; CHPF primarily plays a stabilizing role. Mutational analysis confirms that only CHSY3 (and CHSY1) have bifunctional glycosyltransferase activities. Four heterodimeric complexes (CHSY1-CHPF, CHSY1-CHPF2, CHSY3-CHPF, CHSY3-CHPF2) all exhibit polymerization activity. The mechanism is proposed to be non-processive and distributive.","method":"Cryo-EM structure determination, in vitro glycosylation assay with chemo-enzymatically synthesized fluorescent substrates, mutational analysis of purified complexes, in cellulo complementation assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structure combined with mutagenesis, in vitro reconstitution, and cell-based complementation assay in a single rigorous study","pmids":["41298522"],"is_preprint":false},{"year":2026,"finding":"Cryo-EM structure of CHSY3-CHPF1 (heterodimer) confirms domain architecture: N-terminal CAZy GT31-like domain and C-terminal GT7-like domain in both CHSYs and CHPFs, separated by a cystatin-like linker. Enzymatic analysis of catalytic mutants demonstrates that only the glycosyltransferase domains in CHSY3 are responsible for polymer synthesis (GT31 domain transfers β1,3-GlcA; GT7 domain transfers β1,4-GalNAc), while CHPF1 domains stabilize CHSY3 functional domains but do not contribute to catalysis.","method":"Cryo-EM structure, sequence alignment and structural modeling, catalytic mutant enzymatic analysis, co-expression of CHPF and CHSY for soluble heterodimer formation","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structure with catalytic mutagenesis and enzymatic characterization, independently replicating and extending prior structural work","pmids":["42204168"],"is_preprint":false},{"year":2020,"finding":"CHSY3 knockout in mice (CRISPR-Cas9) causes spontaneous intervertebral disc degeneration with increased catabolic and decreased anabolic changes in nucleus pulposus (NP) cells. Mechanistically, CHSY3 loss downregulates Hippo signaling and reduces YAP1 activation via actin tension, independently of Hippo/LATS signaling.","method":"CRISPR-Cas9 knockout mouse model, RNA-seq, bioinformatic pathway analysis, functional cellular assays in NP cells","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined phenotype and RNA-seq pathway analysis, single lab but multiple methods","pmids":["33089528"],"is_preprint":false},{"year":2021,"finding":"CHSY3 (ChSy-2) knockout via CRISPR/Cas9 in JEG3 choriocarcinoma cells significantly reduced placental-like chondroitin sulfate A (pl-CSA) levels, and this reduction inhibited cell proliferation, migration, invasion, colony formation in vitro, and tumorigenesis and metastasis in xenograft models in vivo.","method":"CRISPR/Cas9 knockout, immunofluorescence, flow cytometry, western blot, ELISA, proliferation assay, scratch-wound assay, transwell invasion assay, soft agar colony formation, xenograft tumor models","journal":"International journal of medical sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with multiple orthogonal cellular and in vivo phenotypic readouts, single lab","pmids":["33390789"],"is_preprint":false},{"year":2023,"finding":"Low-dose celecoxib upregulates CHSY3 expression; in a lumbar spine instability-induced mouse IDD model, low-dose celecoxib inhibited intervertebral disc degeneration in CHSY3 wild-type mice but not in CHSY3 knockout mice, demonstrating that CHSY3 is required for celecoxib's protective effect against IDD.","method":"CHSY3 knockout mouse model, lumbar spine instability-induced IDD model, PCL nanofiber celecoxib delivery, in vitro celecoxib release assay, rabbit puncture-induced IDD model","journal":"Journal of nanobiotechnology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis using KO mouse with defined pharmacological intervention and disease phenotype, single lab","pmids":["36864461"],"is_preprint":false},{"year":2013,"finding":"A single zebrafish orthologue of human CHSY3 exists and is spatially and temporally expressed during early zebrafish development; overlapping expression of multiple CS/DS glycosyltransferases coincides with high CS/DS deposition, suggesting cooperative function in chondroitin sulfate biosynthesis.","method":"In situ hybridization, phylogenetic/homology analysis, CS/DS quantification during zebrafish development","journal":"Developmental dynamics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — expression/localization data without direct functional manipulation of CHSY3 specifically","pmids":["23703795"],"is_preprint":false}],"current_model":"CHSY3 is a bifunctional type II membrane glycosyltransferase with both β1,3-glucuronyltransferase (GT31-like domain) and β1,4-N-acetylgalactosaminyltransferase (GT7-like domain) activities that, while unable to polymerize chondroitin alone, forms obligate heterodimeric complexes with CHPF or CHPF2 to achieve processive chondroitin sulfate chain polymerization; cryo-EM structures of CHSY3-CHPF complexes reveal that CHSY3 provides all catalytic activity while CHPF plays a stabilizing role, and in vivo, CHSY3-mediated CS biosynthesis is required for nucleus pulposus homeostasis, with its loss causing spontaneous intervertebral disc degeneration through actin tension-mediated YAP1 signaling."},"narrative":{"mechanistic_narrative":"CHSY3 is a type II membrane glycosyltransferase that drives elongation of chondroitin sulfate (CS) chains, providing the catalytic core of the CS polymerization machinery [PMID:12907687, PMID:41298522]. It is bifunctional, carrying an N-terminal GT31-like domain that transfers β1,3-glucuronic acid and a C-terminal GT7-like domain that transfers β1,4-N-acetylgalactosamine, separated by a cystatin-like linker, thereby building the alternating GlcUAβ1-3GalNAc/GalNAcβ1-4GlcUA disaccharide repeat at the nonreducing terminus [PMID:12907687, PMID:41298522, PMID:42204168]. CHSY3 alone cannot polymerize chondroitin; processive chain extension requires its assembly into heterodimeric complexes with partner proteins ChSy-1, CHPF, or CHPF2, and complex formation alone is insufficient because catalytic activity of CHSY3 itself is obligatory — a binding-competent but catalytically dead mutant fails to support polymerization [PMID:17253960, PMID:18316376]. Cryo-EM structures of CHSY3-CHPF and CHSY3-CHPF1 heterodimers establish that CHSY3 supplies all catalytic activity while the CHPF subunit serves a stabilizing structural role [PMID:41298522, PMID:42204168]. Physiologically, CHSY3-dependent CS biosynthesis maintains nucleus pulposus homeostasis: its loss in mice causes spontaneous intervertebral disc degeneration through reduced YAP1 activation via actin tension [PMID:33089528], and CHSY3 is required for the protective anti-degenerative effect of low-dose celecoxib [PMID:36864461]. In choriocarcinoma cells, CHSY3 sustains placental-type CS-A production that supports proliferation, invasion, and tumorigenesis [PMID:33390789].","teleology":[{"year":2003,"claim":"Established that CHSY3 is an enzyme with dual transferase activities acting on CS chains, defining its biochemical identity but also revealing it cannot work alone.","evidence":"Recombinant enzyme expression in COS-7 cells with in vitro glycosyltransferase assays on chondroitin/CS acceptors","pmids":["12907687"],"confidence":"High","gaps":["Did not explain how polymerization is achieved when the enzyme cannot polymerize alone","No structural basis for the two activities"]},{"year":2007,"claim":"Resolved why CHSY3 cannot polymerize alone by showing it must physically partner with ChSy-1 or ChPF to acquire polymerization activity, and confirmed cellular relevance via knockdown/overexpression.","evidence":"Pull-down assays, co-expression activity reconstitution, RNAi and overexpression with CS quantification in HeLa cells","pmids":["17253960"],"confidence":"High","gaps":["Stoichiometry and architecture of the complexes unknown","Relative catalytic contribution of each subunit unresolved"]},{"year":2008,"claim":"Demonstrated that CHSY3's own catalytic activity, not merely its presence in a complex, is required for polymerization, separating the binding and catalytic functions of complex members.","evidence":"Co-expression with catalytically inactive mutant analysis and in vitro polymerization on linkage-region tetrasaccharide acceptor, plus RNAi/overexpression in HeLa cells","pmids":["18316376"],"confidence":"High","gaps":["Mechanism of how partners enable processivity unknown","No structural model of the active complex"]},{"year":2020,"claim":"Connected CHSY3 enzymatic function to an in vivo physiological role, showing CS biosynthesis maintains intervertebral disc homeostasis through actin-tension-mediated YAP1 signaling.","evidence":"CRISPR-Cas9 knockout mouse, RNA-seq, pathway analysis, and functional assays in nucleus pulposus cells","pmids":["33089528"],"confidence":"Medium","gaps":["Single lab","Direct mechanistic link from CS loss to actin tension not fully defined"]},{"year":2021,"claim":"Extended CHSY3's role beyond cartilage/disc biology, implicating it in placental-type CS-A production that supports tumor cell proliferation and metastasis.","evidence":"CRISPR/Cas9 knockout in JEG3 choriocarcinoma cells with in vitro phenotypic assays and xenograft models","pmids":["33390789"],"confidence":"Medium","gaps":["Single lab","Molecular pathway downstream of pl-CSA loss not defined"]},{"year":2023,"claim":"Placed CHSY3 epistatically downstream of a therapeutic intervention, showing it is required for celecoxib-mediated protection against disc degeneration.","evidence":"Genetic epistasis with CHSY3 knockout mice in a lumbar instability IDD model with celecoxib delivery","pmids":["36864461"],"confidence":"Medium","gaps":["Mechanism linking celecoxib to CHSY3 upregulation unknown","Single lab"]},{"year":2025,"claim":"Provided the structural basis for CHSY3-driven polymerization, showing it carries GT31 and GT7 domains contributing all catalysis while CHPF/CHPF2 stabilize the complex.","evidence":"Cryo-EM of CHSY3-CHPF complex with mutational analysis, in vitro glycosylation on fluorescent substrates, and in cellulo complementation","pmids":["41298522"],"confidence":"High","gaps":["Processive vs. distributive mechanism still under definition","How four distinct heterodimers achieve different chain lengths unresolved"]},{"year":2026,"claim":"Independently confirmed the CHSY3-CHPF1 domain architecture and the catalytic division of labor, solidifying CHSY3 as the sole catalytic subunit.","evidence":"Cryo-EM of CHSY3-CHPF1 heterodimer, structural modeling, and catalytic mutant enzymatic analysis","pmids":["42204168"],"confidence":"High","gaps":["Full polymerization elongation cycle not captured structurally","Regulation of complex assembly in vivo unknown"]},{"year":null,"claim":"How CHSY3 complex assembly and CS chain-length output are regulated in different tissues, and the precise route from CS loss to YAP1/actin-tension signaling, remain open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No in vivo data on which partner CHSY3 uses in each tissue","Direct biochemical link between CS and actin/YAP signaling not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,2,3,4]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,3,4]}],"localization":[],"pathway":[{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[0,5]}],"complexes":["CHSY3-CHPF heterodimer","CHSY3-CHPF2 heterodimer"],"partners":["CHPF","CHPF2","CHSY1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9P2E5","full_name":"Chondroitin sulfate glucuronyltransferase","aliases":["CSGlcA-T","Chondroitin glucuronyltransferase","Chondroitin polymerizing factor 2","ChPF-2","Chondroitin synthase 3","ChSy-3","N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase"],"length_aa":772,"mass_kda":85.9,"function":"Transfers glucuronic acid (GlcUA) from UDP-GlcUA to N-acetylgalactosamine residues on the non-reducing end of the elongating chondroitin polymer. Has no N-acetylgalactosaminyltransferase activity","subcellular_location":"Golgi apparatus, Golgi stack membrane","url":"https://www.uniprot.org/uniprotkb/Q9P2E5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CHSY3","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CHSY3","total_profiled":1310},"omim":[{"mim_id":"609963","title":"CHONDROITIN SULFATE SYNTHASE 3; CHSY3","url":"https://www.omim.org/entry/609963"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"blood vessel","ntpm":10.0}],"url":"https://www.proteinatlas.org/search/CHSY3"},"hgnc":{"alias_symbol":["CSS3","CHSY-2"],"prev_symbol":[]},"alphafold":{"accession":"Q9P2E5","domains":[{"cath_id":"3.90.550.50","chopping":"91-310","consensus_level":"high","plddt":90.7415,"start":91,"end":310},{"cath_id":"3.10.450","chopping":"375-470","consensus_level":"high","plddt":92.7126,"start":375,"end":470},{"cath_id":"3.90.550.10","chopping":"488-531_542-630_656-757","consensus_level":"high","plddt":89.4235,"start":488,"end":757}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9P2E5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9P2E5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9P2E5-F1-predicted_aligned_error_v6.png","plddt_mean":84.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CHSY3","jax_strain_url":"https://www.jax.org/strain/search?query=CHSY3"},"sequence":{"accession":"Q9P2E5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9P2E5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9P2E5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9P2E5"}},"corpus_meta":[{"pmid":"18316376","id":"PMC_18316376","title":"Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization: chondroitin polymerization is achieved by multiple enzyme complexes consisting of chondroitin synthase family members.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18316376","citation_count":123,"is_preprint":false},{"pmid":"17253960","id":"PMC_17253960","title":"Involvement of chondroitin sulfate synthase-3 (chondroitin synthase-2) in chondroitin polymerization through its interaction with chondroitin synthase-1 or chondroitin-polymerizing factor.","date":"2007","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/17253960","citation_count":83,"is_preprint":false},{"pmid":"2445463","id":"PMC_2445463","title":"Characteristics of cell lines established from a mixed mesodermal tumor of the human ovary. Carcinomatous cells are changeable to sarcomatous cells.","date":"1987","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/2445463","citation_count":74,"is_preprint":false},{"pmid":"12907687","id":"PMC_12907687","title":"Chondroitin sulfate synthase-3. Molecular cloning and characterization.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12907687","citation_count":61,"is_preprint":false},{"pmid":"19298595","id":"PMC_19298595","title":"Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells.","date":"2009","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/19298595","citation_count":54,"is_preprint":false},{"pmid":"16951076","id":"PMC_16951076","title":"Complex genetic architecture revealed by analysis of high-density lipoprotein cholesterol in chromosome substitution strains and F2 crosses.","date":"2006","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16951076","citation_count":29,"is_preprint":false},{"pmid":"20193695","id":"PMC_20193695","title":"DNA methylation changes in a human cell model of breast cancer progression.","date":"2010","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/20193695","citation_count":26,"is_preprint":false},{"pmid":"23703795","id":"PMC_23703795","title":"Expression of chondroitin/dermatan sulfate glycosyltransferases during early zebrafish development.","date":"2013","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/23703795","citation_count":24,"is_preprint":false},{"pmid":"34966741","id":"PMC_34966741","title":"Glycogenes in Oncofetal Chondroitin Sulfate Biosynthesis are Differently Expressed and Correlated With Immune Response in Placenta and Colorectal Cancer.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34966741","citation_count":21,"is_preprint":false},{"pmid":"29984655","id":"PMC_29984655","title":"Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients' Outcome.","date":"2019","source":"Current cancer drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/29984655","citation_count":18,"is_preprint":false},{"pmid":"33089528","id":"PMC_33089528","title":"Chondroitin synthase-3 regulates nucleus pulposus degeneration through actin-induced YAP signaling.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/33089528","citation_count":15,"is_preprint":false},{"pmid":"25003813","id":"PMC_25003813","title":"Genetic perturbations that impair functional trait interactions lead to reduced bone strength and increased fragility in mice.","date":"2014","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/25003813","citation_count":15,"is_preprint":false},{"pmid":"36009085","id":"PMC_36009085","title":"Integrated Analysis of Cortex Single-Cell Transcriptome and Serum Proteome Reveals the Novel Biomarkers in Alzheimer's Disease.","date":"2022","source":"Brain sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36009085","citation_count":14,"is_preprint":false},{"pmid":"36864461","id":"PMC_36864461","title":"Low-dose celecoxib-loaded PCL fibers reverse intervertebral disc degeneration by up-regulating CHSY3 expression.","date":"2023","source":"Journal of nanobiotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36864461","citation_count":13,"is_preprint":false},{"pmid":"11145744","id":"PMC_11145744","title":"Calcium responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and somatostatin in phospholipase css3 knockout mice.","date":"2001","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/11145744","citation_count":12,"is_preprint":false},{"pmid":"36184273","id":"PMC_36184273","title":"Familial Clustering and Genetic Analysis of Severe Thumb Carpometacarpal Joint Osteoarthritis in a Large Statewide Cohort.","date":"2022","source":"The Journal of hand surgery","url":"https://pubmed.ncbi.nlm.nih.gov/36184273","citation_count":10,"is_preprint":false},{"pmid":"37595009","id":"PMC_37595009","title":"Genome-wide association study on abdomen depth, head width, hip width, and withers height in native cattle of Guilan (Bos indicus).","date":"2023","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/37595009","citation_count":9,"is_preprint":false},{"pmid":"34525476","id":"PMC_34525476","title":"Expression and Clinical Significance of lncRNA OSER1-AS1 in Peripheral Blood of Patients with Non-Small Cell Lung Cancer.","date":"2021","source":"Cells, tissues, organs","url":"https://pubmed.ncbi.nlm.nih.gov/34525476","citation_count":4,"is_preprint":false},{"pmid":"19438813","id":"PMC_19438813","title":"Derivation of a novel undifferentiated human foetal phenotype in serum-free cultures with BMP-2.","date":"2009","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19438813","citation_count":4,"is_preprint":false},{"pmid":"37604023","id":"PMC_37604023","title":"Comprehensive transcriptomic and metabolomic analysis of the effect of feed restriction on duck sternal development.","date":"2023","source":"Poultry science","url":"https://pubmed.ncbi.nlm.nih.gov/37604023","citation_count":3,"is_preprint":false},{"pmid":"25828361","id":"PMC_25828361","title":"Basing RNA-seq explored the regulatory mechanism of the carbohydrate metabolism pathways during chicken male germ cell differentiation.","date":"2015","source":"In vitro cellular & developmental biology. Animal","url":"https://pubmed.ncbi.nlm.nih.gov/25828361","citation_count":3,"is_preprint":false},{"pmid":"33390789","id":"PMC_33390789","title":"Reduction of pl-CSA through ChSy-2 knockout inhibits tumorigenesis and metastasis of choriocarcinoma in JEG3 cells.","date":"2021","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33390789","citation_count":2,"is_preprint":false},{"pmid":"41298522","id":"PMC_41298522","title":"Structural basis for human chondroitin sulfate chain polymerization.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/41298522","citation_count":2,"is_preprint":false},{"pmid":"39563460","id":"PMC_39563460","title":"A novel mutation in SMARCB1 associated with adult Coffin-Siris syndrome and meningioma.","date":"2024","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/39563460","citation_count":2,"is_preprint":false},{"pmid":"40420150","id":"PMC_40420150","title":"Revealing a novel Decorin-expressing tumor stromal subset in hepatocellular carcinoma via integrative analysis single-cell RNA sequencing.","date":"2025","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/40420150","citation_count":1,"is_preprint":false},{"pmid":"42204168","id":"PMC_42204168","title":"Structural basis of chondroitin sulfate backbone polymer synthesis.","date":"2026","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/42204168","citation_count":0,"is_preprint":false},{"pmid":"41585630","id":"PMC_41585630","title":"Human molecular mechanisms of lumbar disc degeneration: A scoping review.","date":"2025","source":"Spine open","url":"https://pubmed.ncbi.nlm.nih.gov/41585630","citation_count":0,"is_preprint":false},{"pmid":"35331724","id":"PMC_35331724","title":"Adherence of Candida albicans and Malassezia Species to Skin Cells Induces Changes in the Expression of Genes Responsible for Heparan and Chondroitin Sulfate Chain Synthesis.","date":"2022","source":"Actas dermo-sifiliograficas","url":"https://pubmed.ncbi.nlm.nih.gov/35331724","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":17382,"output_tokens":2733,"usd":0.046571,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9939,"output_tokens":2823,"usd":0.060135,"stage2_stop_reason":"end_turn"},"total_usd":0.106706,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"CHSY3 (CSS3) encodes a type II membrane protein with both glucuronyltransferase (GlcAT-II) and N-acetylgalactosaminyltransferase (GalNAcT-II) activities responsible for elongation of chondroitin sulfate chains, producing GlcUAβ1-3GalNAc and GalNAcβ1-4GlcUA linkages at the nonreducing terminus, but cannot polymerize chondroitin chains alone.\",\n      \"method\": \"Recombinant enzyme expression in COS-7 cells, in vitro glycosyltransferase assays with chondroitin/CS polymer acceptor substrates\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro enzymatic characterization with defined substrates, replicated by subsequent studies\",\n      \"pmids\": [\"12907687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CHSY3 (CSS3) interacts with ChSy-1 and ChPF via direct protein-protein interactions; co-expression of CSS3 with either ChSy-1 or ChPF confers chondroitin polymerization activity not present in CSS3 alone. Overexpression of CSS3 increases CS in HeLa cells; RNAi knockdown reduces CS levels.\",\n      \"method\": \"Pull-down assays (protein-protein interaction), co-expression in mammalian cells with glycosyltransferase activity assays, RNAi knockdown and overexpression with CS quantification in HeLa cells\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (pull-down, co-expression activity assay, RNAi, overexpression) in one study, independently replicated in subsequent work\",\n      \"pmids\": [\"17253960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CHSY3 (renamed ChSy-3 from CSGlcA-T) interacts with ChSy-1, ChSy-2 (CSS3/CHSY3's alias used for a different member here — note: in this paper CSGlcA-T is the subject being renamed ChSy-3), and ChPF; these heteromeric complexes exhibit chondroitin polymerization activity with distinct chain lengths depending on the combination. The glycosyltransferase activity of CSGlcA-T is required for polymerization, as a catalytically inactive mutant that retains binding to other ChSy members cannot support polymerization.\",\n      \"method\": \"Co-expression in cells, in vitro polymerization assay with truncated linkage region tetrasaccharide acceptor, catalytically inactive mutant analysis, RNAi knockdown and overexpression with CS quantification in HeLa cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — active-site mutagenesis combined with reconstitution assay and RNAi, multiple orthogonal methods\",\n      \"pmids\": [\"18316376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structure of the CHSY3-CHPF heterodimeric complex reveals the molecular basis of chondroitin sulfate chain polymerization. CHSY3 contains an N-terminal GT31-like domain (transfers β1,3-GlcA) and a C-terminal GT7-like domain (transfers β1,4-GalNAc) separated by a cystatin-like linker; CHPF primarily plays a stabilizing role. Mutational analysis confirms that only CHSY3 (and CHSY1) have bifunctional glycosyltransferase activities. Four heterodimeric complexes (CHSY1-CHPF, CHSY1-CHPF2, CHSY3-CHPF, CHSY3-CHPF2) all exhibit polymerization activity. The mechanism is proposed to be non-processive and distributive.\",\n      \"method\": \"Cryo-EM structure determination, in vitro glycosylation assay with chemo-enzymatically synthesized fluorescent substrates, mutational analysis of purified complexes, in cellulo complementation assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structure combined with mutagenesis, in vitro reconstitution, and cell-based complementation assay in a single rigorous study\",\n      \"pmids\": [\"41298522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Cryo-EM structure of CHSY3-CHPF1 (heterodimer) confirms domain architecture: N-terminal CAZy GT31-like domain and C-terminal GT7-like domain in both CHSYs and CHPFs, separated by a cystatin-like linker. Enzymatic analysis of catalytic mutants demonstrates that only the glycosyltransferase domains in CHSY3 are responsible for polymer synthesis (GT31 domain transfers β1,3-GlcA; GT7 domain transfers β1,4-GalNAc), while CHPF1 domains stabilize CHSY3 functional domains but do not contribute to catalysis.\",\n      \"method\": \"Cryo-EM structure, sequence alignment and structural modeling, catalytic mutant enzymatic analysis, co-expression of CHPF and CHSY for soluble heterodimer formation\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structure with catalytic mutagenesis and enzymatic characterization, independently replicating and extending prior structural work\",\n      \"pmids\": [\"42204168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CHSY3 knockout in mice (CRISPR-Cas9) causes spontaneous intervertebral disc degeneration with increased catabolic and decreased anabolic changes in nucleus pulposus (NP) cells. Mechanistically, CHSY3 loss downregulates Hippo signaling and reduces YAP1 activation via actin tension, independently of Hippo/LATS signaling.\",\n      \"method\": \"CRISPR-Cas9 knockout mouse model, RNA-seq, bioinformatic pathway analysis, functional cellular assays in NP cells\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined phenotype and RNA-seq pathway analysis, single lab but multiple methods\",\n      \"pmids\": [\"33089528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CHSY3 (ChSy-2) knockout via CRISPR/Cas9 in JEG3 choriocarcinoma cells significantly reduced placental-like chondroitin sulfate A (pl-CSA) levels, and this reduction inhibited cell proliferation, migration, invasion, colony formation in vitro, and tumorigenesis and metastasis in xenograft models in vivo.\",\n      \"method\": \"CRISPR/Cas9 knockout, immunofluorescence, flow cytometry, western blot, ELISA, proliferation assay, scratch-wound assay, transwell invasion assay, soft agar colony formation, xenograft tumor models\",\n      \"journal\": \"International journal of medical sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with multiple orthogonal cellular and in vivo phenotypic readouts, single lab\",\n      \"pmids\": [\"33390789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Low-dose celecoxib upregulates CHSY3 expression; in a lumbar spine instability-induced mouse IDD model, low-dose celecoxib inhibited intervertebral disc degeneration in CHSY3 wild-type mice but not in CHSY3 knockout mice, demonstrating that CHSY3 is required for celecoxib's protective effect against IDD.\",\n      \"method\": \"CHSY3 knockout mouse model, lumbar spine instability-induced IDD model, PCL nanofiber celecoxib delivery, in vitro celecoxib release assay, rabbit puncture-induced IDD model\",\n      \"journal\": \"Journal of nanobiotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis using KO mouse with defined pharmacological intervention and disease phenotype, single lab\",\n      \"pmids\": [\"36864461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A single zebrafish orthologue of human CHSY3 exists and is spatially and temporally expressed during early zebrafish development; overlapping expression of multiple CS/DS glycosyltransferases coincides with high CS/DS deposition, suggesting cooperative function in chondroitin sulfate biosynthesis.\",\n      \"method\": \"In situ hybridization, phylogenetic/homology analysis, CS/DS quantification during zebrafish development\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — expression/localization data without direct functional manipulation of CHSY3 specifically\",\n      \"pmids\": [\"23703795\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CHSY3 is a bifunctional type II membrane glycosyltransferase with both β1,3-glucuronyltransferase (GT31-like domain) and β1,4-N-acetylgalactosaminyltransferase (GT7-like domain) activities that, while unable to polymerize chondroitin alone, forms obligate heterodimeric complexes with CHPF or CHPF2 to achieve processive chondroitin sulfate chain polymerization; cryo-EM structures of CHSY3-CHPF complexes reveal that CHSY3 provides all catalytic activity while CHPF plays a stabilizing role, and in vivo, CHSY3-mediated CS biosynthesis is required for nucleus pulposus homeostasis, with its loss causing spontaneous intervertebral disc degeneration through actin tension-mediated YAP1 signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CHSY3 is a type II membrane glycosyltransferase that drives elongation of chondroitin sulfate (CS) chains, providing the catalytic core of the CS polymerization machinery [#0, #3]. It is bifunctional, carrying an N-terminal GT31-like domain that transfers \\u03b21,3-glucuronic acid and a C-terminal GT7-like domain that transfers \\u03b21,4-N-acetylgalactosamine, separated by a cystatin-like linker, thereby building the alternating GlcUA\\u03b21-3GalNAc/GalNAc\\u03b21-4GlcUA disaccharide repeat at the nonreducing terminus [#0, #3, #4]. CHSY3 alone cannot polymerize chondroitin; processive chain extension requires its assembly into heterodimeric complexes with partner proteins ChSy-1, CHPF, or CHPF2, and complex formation alone is insufficient because catalytic activity of CHSY3 itself is obligatory \\u2014 a binding-competent but catalytically dead mutant fails to support polymerization [#1, #2]. Cryo-EM structures of CHSY3-CHPF and CHSY3-CHPF1 heterodimers establish that CHSY3 supplies all catalytic activity while the CHPF subunit serves a stabilizing structural role [#3, #4]. Physiologically, CHSY3-dependent CS biosynthesis maintains nucleus pulposus homeostasis: its loss in mice causes spontaneous intervertebral disc degeneration through reduced YAP1 activation via actin tension [#5], and CHSY3 is required for the protective anti-degenerative effect of low-dose celecoxib [#7]. In choriocarcinoma cells, CHSY3 sustains placental-type CS-A production that supports proliferation, invasion, and tumorigenesis [#6].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Established that CHSY3 is an enzyme with dual transferase activities acting on CS chains, defining its biochemical identity but also revealing it cannot work alone.\",\n      \"evidence\": \"Recombinant enzyme expression in COS-7 cells with in vitro glycosyltransferase assays on chondroitin/CS acceptors\",\n      \"pmids\": [\"12907687\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not explain how polymerization is achieved when the enzyme cannot polymerize alone\", \"No structural basis for the two activities\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved why CHSY3 cannot polymerize alone by showing it must physically partner with ChSy-1 or ChPF to acquire polymerization activity, and confirmed cellular relevance via knockdown/overexpression.\",\n      \"evidence\": \"Pull-down assays, co-expression activity reconstitution, RNAi and overexpression with CS quantification in HeLa cells\",\n      \"pmids\": [\"17253960\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and architecture of the complexes unknown\", \"Relative catalytic contribution of each subunit unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrated that CHSY3's own catalytic activity, not merely its presence in a complex, is required for polymerization, separating the binding and catalytic functions of complex members.\",\n      \"evidence\": \"Co-expression with catalytically inactive mutant analysis and in vitro polymerization on linkage-region tetrasaccharide acceptor, plus RNAi/overexpression in HeLa cells\",\n      \"pmids\": [\"18316376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of how partners enable processivity unknown\", \"No structural model of the active complex\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Connected CHSY3 enzymatic function to an in vivo physiological role, showing CS biosynthesis maintains intervertebral disc homeostasis through actin-tension-mediated YAP1 signaling.\",\n      \"evidence\": \"CRISPR-Cas9 knockout mouse, RNA-seq, pathway analysis, and functional assays in nucleus pulposus cells\",\n      \"pmids\": [\"33089528\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Direct mechanistic link from CS loss to actin tension not fully defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extended CHSY3's role beyond cartilage/disc biology, implicating it in placental-type CS-A production that supports tumor cell proliferation and metastasis.\",\n      \"evidence\": \"CRISPR/Cas9 knockout in JEG3 choriocarcinoma cells with in vitro phenotypic assays and xenograft models\",\n      \"pmids\": [\"33390789\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Molecular pathway downstream of pl-CSA loss not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Placed CHSY3 epistatically downstream of a therapeutic intervention, showing it is required for celecoxib-mediated protection against disc degeneration.\",\n      \"evidence\": \"Genetic epistasis with CHSY3 knockout mice in a lumbar instability IDD model with celecoxib delivery\",\n      \"pmids\": [\"36864461\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking celecoxib to CHSY3 upregulation unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Provided the structural basis for CHSY3-driven polymerization, showing it carries GT31 and GT7 domains contributing all catalysis while CHPF/CHPF2 stabilize the complex.\",\n      \"evidence\": \"Cryo-EM of CHSY3-CHPF complex with mutational analysis, in vitro glycosylation on fluorescent substrates, and in cellulo complementation\",\n      \"pmids\": [\"41298522\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Processive vs. distributive mechanism still under definition\", \"How four distinct heterodimers achieve different chain lengths unresolved\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Independently confirmed the CHSY3-CHPF1 domain architecture and the catalytic division of labor, solidifying CHSY3 as the sole catalytic subunit.\",\n      \"evidence\": \"Cryo-EM of CHSY3-CHPF1 heterodimer, structural modeling, and catalytic mutant enzymatic analysis\",\n      \"pmids\": [\"42204168\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full polymerization elongation cycle not captured structurally\", \"Regulation of complex assembly in vivo unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CHSY3 complex assembly and CS chain-length output are regulated in different tissues, and the precise route from CS loss to YAP1/actin-tension signaling, remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vivo data on which partner CHSY3 uses in each tissue\", \"Direct biochemical link between CS and actin/YAP signaling not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 2, 3, 4]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 3, 4]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"R-HSA-1630316\", \"supporting_discovery_ids\": []}\n    ],\n    \"complexes\": [\"CHSY3-CHPF heterodimer\", \"CHSY3-CHPF2 heterodimer\"],\n    \"partners\": [\"CHPF\", \"CHPF2\", \"CHSY1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":6,"faith_total":6,"faith_pct":100.0}}